Share-based Compensation (Tables)

9 Months Ended

Dec. 31, 2017

Summary of share-based compensation expense for options

The following table summarizes the share-based compensation expense for options, SSARs, restricted and performance awards included in the Condensed Consolidated Statements of Operations:



	Three months ended					Nine months ended
	December 31,					December 31,
(In thousands)	2017		2016			2017		2016
Product development	$	456	$	498		$	982	$	826
Sales and marketing	173		124			529		177
General and administrative	829		(680		)	2,265		(221		)
Total share-based compensation expense	1,458		(58		)	3,776		782

Activity related SSARs award

The following table summarizes the activity during the nine months ended December 31, 2017 for SSARs awarded under the 2011 and 2016 Plans:



	Number of Rights		Weighted- Average Exercise Price		Remaining Contractual Term	Aggregate Intrinsic Value
(In thousands, except share and per share data)			(per right)		(in years)
Outstanding at April 1, 2017	1,094,978		$	10.44
Granted	204,213		10.56
Exercised	(41,691	)	9.14
Forfeited	(55,530	)	9.98
Cancelled/expired	(54,679	)	9.56
Outstanding at December 31, 2017	1,147,291		$	10.58	5.4	$	2,038
Exercisable at December 31, 2017	245,064		$	10.26	3.4	$	574

The following table summarizes the activity during the nine months ended December 31, 2017 for restricted shares awarded under the 2016 and 2011 Plans:



	Number of Shares		Weighted- Average Grant- Date Fair Value
(In thousands, except share and per share data)			(per share)
Outstanding at April 1, 2017	490,355		$	10.72
Granted	251,010		11.02
Vested	(221,897	)	11.29
Forfeited	(80,793	)	10.72
Outstanding at December 31, 2017	438,675		$	10.60

Performance shares awarded

The following table summarizes the activity during the nine months ended December 31, 2017 for the performance shares awarded under the 2016 Plan:



	Number of Shares

Outstanding at April 1, 2017	—
Granted	91,463
Vested	—
Outstanding at December 31, 2017	91,463